Evidence map›Paper›PMID 42436725›Full record

ArticleMagnetic resonance letters2026

Chuancheng Shi, Kai Huang, Xingrui Wang, Yan Zhou, Mengqiu Cao, Daxiu Wei, Yefeng Yao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Magnetic resonance letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chuancheng ShiInstitute of Magnetic Resonance and Molecular Imaging in Medicine, Shanghai Key Laboratory of Magnetic Resonance, School of Physics, East China Normal University, Shanghai, 200241, China.
Kai HuangInstitute of Magnetic Resonance and Molecular Imaging in Medicine, Shanghai Key Laboratory of Magnetic Resonance, School of Physics, East China Normal University, Shanghai, 200241, China.
Xingrui WangDepartments of Radiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Yan ZhouDepartments of Radiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Mengqiu CaoDepartments of Radiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Daxiu WeiInstitute of Magnetic Resonance and Molecular Imaging in Medicine, Shanghai Key Laboratory of Magnetic Resonance, School of Physics, East China Normal University, Shanghai, 200241, China.
Yefeng YaoInstitute of Magnetic Resonance and Molecular Imaging in Medicine, Shanghai Key Laboratory of Magnetic Resonance, School of Physics, East China Normal University, Shanghai, 200241, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

2-hydroxyglutarate (2-HG) is a key metabolic biomarker for identifying IDH-mutant gliomas. Non-invasive and accurate detection of 2-HG is of great significance for the early diagnosis of diseases and dynamic monitoring of therapeutic efficacy. However, conventional magnetic resonance spectroscopy (MRS) faces challenges in detecting 2-HG

Indexed as

2-hydroxyglutaric acidIDH gliomaMagnetic resonance spectroscopyOptimal control pulse

Identifiers

PMID42436725
PMCPMC13355761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.